Zobrazeno 1 - 10 of 208 pro vyhledávání: '"Sarasohn, D."'
1
Akademický článek
A phase 2 trial of zanidatamab in HER2-overexpressed advanced endometrial carcinoma and carcinosarcoma (ZW25-IST-2).
Autor: Lumish M; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, United States of America; Department of Medicine, Weill Cornell Medical College, New York, NY, United States of America., Chui MH; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, United States of America., Zhou Q; Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, United States of America., Iasonos A; Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, United States of America., Sarasohn D; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, United States of America., Cohen S; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, United States of America; Department of Medicine, Weill Cornell Medical College, New York, NY, United States of America., Friedman C; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, United States of America; Department of Medicine, Weill Cornell Medical College, New York, NY, United States of America., Grisham R; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, United States of America; Department of Medicine, Weill Cornell Medical College, New York, NY, United States of America., Konner J; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, United States of America; Department of Medicine, Weill Cornell Medical College, New York, NY, United States of America., Kyi C; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, United States of America; Department of Medicine, Weill Cornell Medical College, New York, NY, United States of America., Rubinstein M; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, United States of America; Department of Medicine, Weill Cornell Medical College, New York, NY, United States of America., Troso-Sandoval T; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, United States of America; Department of Medicine, Weill Cornell Medical College, New York, NY, United States of America., Aghajanian C; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, United States of America; Department of Medicine, Weill Cornell Medical College, New York, NY, United States of America., Makker V; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, United States of America; Department of Medicine, Weill Cornell Medical College, New York, NY, United States of America. Electronic address: makkerv@mskcc.org.
Publikováno v: Gynecologic oncology [Gynecol Oncol] 2024 Mar; Vol. 182, pp. 75-81. Date of Electronic Publication: 2024 Jan 22.
Zobrazit plný text záznamu
2
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
3
Report
Tumor lenvatinib addiction and withdrawal rebound response in patients with advanced endometrial cancer.
Autor: Lam C; Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Sarasohn D; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Weigelt B; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Zamarin D; Division of Gynecological Medical Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Weill Cornell Medical College, New York, NY, USA.
Publikováno v: Gynecologic oncology reports [Gynecol Oncol Rep] 2023 Aug 11; Vol. 49, pp. 101258. Date of Electronic Publication: 2023 Aug 11 (Print Publication: 2023).
Zobrazit plný text záznamu
4
Akademický článek
Phase I Study of a Multivalent WT1 Peptide Vaccine (Galinpepimut-S) in Combination with Nivolumab in Patients with WT1-Expressing Ovarian Cancer in Second or Third Remission.
Autor: Manning-Geist BL; Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Gnjatic S; Immune Monitoring Facility, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.; Tisch Cancer Institute, Precision Immunology Institute, Human Immune Monitoring Center, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., Aghajanian C; Department of Medicine, Weill Cornell Medical Center, New York, NY 10065, USA.; Gynecologic Medical Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Konner J; Department of Medicine, Weill Cornell Medical Center, New York, NY 10065, USA.; Gynecologic Medical Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Kim SH; Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Sarasohn D; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Soldan K; Gynecologic Medical Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Tew WP; Department of Medicine, Weill Cornell Medical Center, New York, NY 10065, USA.; Gynecologic Medical Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Sarlis NJ; SELLAS Life Sciences Group, Inc., New York, NY 10036, USA., Zamarin D; Department of Medicine, Weill Cornell Medical Center, New York, NY 10065, USA.; Gynecologic Medical Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Kravetz S; Gynecologic Medical Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Laface I; Tisch Cancer Institute, Precision Immunology Institute, Human Immune Monitoring Center, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., Rasalan-Ho T; Immune Monitoring Facility, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Qi J; Immune Monitoring Facility, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.; Tisch Cancer Institute, Precision Immunology Institute, Human Immune Monitoring Center, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., Wong P; Immune Monitoring Facility, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Sabbatini PJ; Department of Medicine, Weill Cornell Medical Center, New York, NY 10065, USA.; Gynecologic Medical Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., O'Cearbhaill RE; Department of Medicine, Weill Cornell Medical Center, New York, NY 10065, USA.; Gynecologic Medical Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.; Department of Medicine, University of Galway, H91 YR71 Galway, Ireland.
Publikováno v: Cancers [Cancers (Basel)] 2023 Feb 25; Vol. 15 (5). Date of Electronic Publication: 2023 Feb 25.
Zobrazit plný text záznamu
5
Akademický článek
Durvalumab with or without tremelimumab in patients with persistent or recurrent endometrial cancer or endometrial carcinosarcoma: A randomized open-label phase 2 study.
Autor: Rubinstein MM; Gynecologic Medical Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weill Cornell Medical College, New York, NY, USA. Electronic address: rubinstm@mskcc.org., Doria ER; Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Konner J; Gynecologic Medical Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weill Cornell Medical College, New York, NY, USA., Lichtman S; Gynecologic Medical Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weill Cornell Medical College, New York, NY, USA., Zhou Q; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Iasonos A; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Sarasohn D; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Troso-Sandoval T; Gynecologic Medical Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weill Cornell Medical College, New York, NY, USA., Friedman C; Gynecologic Medical Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weill Cornell Medical College, New York, NY, USA., O'Cearbhaill R; Gynecologic Medical Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weill Cornell Medical College, New York, NY, USA., Cadoo K; St. James's Hospital, Trinity College Dublin, Trinity St. James's Cancer Institute, Dublin, Ireland., Kyi C; Gynecologic Medical Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weill Cornell Medical College, New York, NY, USA., Cohen S; Gynecologic Medical Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weill Cornell Medical College, New York, NY, USA., Soldan K; Department of Nursing, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Billinson E; Gynecologic Medical Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Caird I; Gynecologic Medical Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Jang D; Gynecologic Medical Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Eid K; Gynecologic Medical Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Shah P; Gynecologic Medical Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Guillen J; Gynecologic Medical Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Aghajanian C; Gynecologic Medical Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weill Cornell Medical College, New York, NY, USA., Zamarin D; Gynecologic Medical Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weill Cornell Medical College, New York, NY, USA., Makker V; Gynecologic Medical Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weill Cornell Medical College, New York, NY, USA.
Publikováno v: Gynecologic oncology [Gynecol Oncol] 2023 Feb; Vol. 169, pp. 64-69. Date of Electronic Publication: 2022 Dec 10.
Zobrazit plný text záznamu
6
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
7
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
9
Akademický článek
Waxing and waning pattern of mTOR inhibitor-associated pneumonitis in renal cell carcinoma patients: A retrospective observational study.
Autor: Gluskin J; Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. Electronic address: gluskinj@mskcc.org., Plodkowski A; Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA., Girshman J; Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA., Sarasohn D; Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA., Viteri-Jusué A; Department of Radiology, Hospital Universitario Araba, Bilbao, Spain., Hayan S; St. George's University School of Medicine, University Centre Grenada, West Indies, Grenada., Torrisi J; Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA.
Publikováno v: Clinical imaging [Clin Imaging] 2021 Mar; Vol. 71, pp. 29-33. Date of Electronic Publication: 2020 Nov 05.
Zobrazit plný text záznamu
10
Akademický článek
Multiparametric Ultrasound for Focal Testicular Pathology: A Ten-Year Retrospective Review.
Autor: Huang, Dean Y.1,2 (AUTHOR) dean.huang@nhs.net, Alsadiq, Majed3 (AUTHOR), Yusuf, Gibran T.1,2 (AUTHOR), Deganello, Annamaria1,2 (AUTHOR), Sellars, Maria E.1 (AUTHOR), Sidhu, Paul S.1,2 (AUTHOR)
Publikováno v: Cancers. Jul2024, Vol. 16 Issue 13, p2309. 17p.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje